Clinical Advisory: CDC Adopts New COVID-19 Vaccine Recommendation for Older Adults
The CDC has updated their Interim Clinical Considerations for Use of COVID-19 Vaccines. It recommends that all adults aged 65 and over receive one additional dose of any updated (2023-2024 formula) COVID-19 vaccine at least four months following their previous dose.
This new guide reviews the types of nebulizers, indications for their use, commonly nebulized medications, and steps for nebulizer administration and cleaning.
Monthly Minute: VALTOCO (Diazepam Nasal Spray) for Seizure Rescue Therapy
Our newest Monthly Minute reviews the usage of VALTOCO for seizure clusters, including clinical benefits, administration, storage, and safety considerations.
PMD Alliance Webinar: Parkinson's Disease — More Than Motor Symptoms
Join the Parkinson & Movement Disorder Alliance for their April 11 webinar and learn about the non-motor symptoms of Parkinson’s disease, including hallucinations and delusions. Explore how to discuss these with a healthcare provider and establish a treatment plan.
Meet Challenges with Compassion with Certified Parkinson Disease Care™
Set your team apart with Certified Parkinson Disease Care™ accreditation from Parkinson & Movement Disorder Alliance. CPDC™ trains your staff to create and deliver care plans with specific attention to the symptoms, medications management, and therapy considerations for a person with Parkinson's disease, providing reassurance and confidence to those impacted and their loved ones.
F757 provides guidance to surveyors on unnecessary medications, including excessive doses, excessive duration, and medications without adequate indications for use. Learn more about how unnecessary medications are defined, what surveyors look for, and how your facility can stay in compliance.
